Higher CCRL2 expression in AML cells is associated with a poorer prognosis [91], and UALCAN analyses show a trend towards worse prognosis with higher CCRL2 expression (p = 0.091) [23,24]. Here, CCRL2 is linked to acute myeloid leukemia.